Skip to main content

The Global Microtomes Market Continues To Grow Owing To the Demand from Various Industrial Laboratories and Clinical Research Centers All Over the World despite Its High Cost

 


The microtomes market refers to the sale and distribution of devices used for cutting very thin slices (sections) of biological tissues, plant specimens, or other materials for microscopic examination. They are commonly used in fields such as histology, pathology, and electron microscopy. The market is driven by factors such as increasing demand for tissue-based diagnostic tests, growth in the field of regenerative medicine, and technological advancements in microtomes. The market is segmented into different types of microtomes, including manual, semi-automated, and fully automated, and by end-users such as research laboratories, hospitals, and diagnostic centers.

Market Dynamics                                               

The main driving factor influencing the growth of the microtomes market is the rapid increase of funding and investment for the development of microtomes by the key players and the demand from diagnostic and clinical research laboratories. For instance, in the financial year 2018, the Indian government spent approximately US$ 15,601 million on research and development sectors. Moreover, the demand for microtomes in the practices of histopathology is expected to boost market growth.

However, the high cost and few disadvantages associated with microtomes are the main restraining factor hindering the market growth. For instance, the cost of Leica Microtome RM2255 is between US$ 6900 to US$ 9800 and is very expensive for developing nations of regions such as Asia Pacific, Africa, and the Middle East.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more